Healthcare News

WALTHAM, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the...

Châtillon, France, le 16 juillet 2026   DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2026 et fait le point sur ses activités Poursuite d’échanges productifs...

Châtillon, France, July 16, 2026 DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update Continued productive engagement with the FDA in support of the BLA...

Industry-wide coverage policy expands reimbursement framework for donor-derived cell-free DNA testingSupports iMDx's commercial strategy in transplant monitoringFinal policy establishes recurring...

Cosmos Health has now repurchased a total of 4,838,000 shares for approximately $1.04 million.

Society for Medical Decision Making Honors UMIT TIROL and Harvard Professor Uwe Siebert with the coveted 2026 Career Achievement Award in Oslo, Norway.

Second-Quarter and First-Half 2026 ResultsConference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,Mr STEFANO GRASSI,...

Second-Quarter and First-Half 2026 ResultsConference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,Mr STEFANO GRASSI,...

Second-Quarter and First-Half 2026 ResultsConference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,Mr STEFANO GRASSI,...

Trethera and UCLA publish peer-reviewed manuscript highlighting dCK as a novel cancer target and TRE-515 as the first clinically tested dCK inhibitor